Effectiveness of Enfortumab-Vedotin for Right Atrial Metastasis Following Total Cystectomy: A Case Report
Author Information
Author(s): Muacevic Alexander, Adler John R, Tokitaka Satoshi, Hirata Hiroshi, Shimo Reiko, Shintaro Oka, Shiraishi Koji
Primary Institution: Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, JPN
Conclusion
Enfortumab-vedotin treatment led to complete remission of bladder cancer metastasis to the right atrium in a patient.
Supporting Evidence
- Cardiac metastases from bladder cancer are extremely rare and typically associated with a poor prognosis.
- The patient achieved complete remission of the right atrial tumor one month after starting enfortumab-vedotin treatment.
- The complete response was maintained for six months after treatment.
Takeaway
A woman with bladder cancer had a tumor in her heart, but after treatment with a special medicine, the tumor disappeared completely.
Methodology
The patient was treated with enfortumab-vedotin after previous treatments, and her response was monitored through imaging.
Limitations
Histopathological information was not available due to the inability to biopsy the cardiac metastases.
Participant Demographics
74-year-old woman with a history of bladder cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website